close
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Glaukos Corporation Common Stock (NY:GKOS)

85.32 +2.23 (+2.68%)
Official Closing Price Updated: 7:00 PM EDT, Oct 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Glaukos Corporation Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Glaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical Platform
From Glaukos Corporation
Via Business Wire
Short Seller Accuses TransMedics Of 'Mafia Style' Scheme, Organ Transplant Company Says Short Seller Manipulating Market
TransMedics faces allegations from Scorpion Capital of fraud and organ trafficking, while the company rebuffs the claims as baseless market manipulation. 
Via Benzinga
Topics Fraud
Glaukos To Rally Around 17%? Here Are 6 Top Analyst Forecasts For Tuesday
 
Via Benzinga
Glaukos Submits New Drug Application to U.S. FDA for Epioxa™
From Glaukos Corporation
Via Business Wire
How Is The Market Feeling About Glaukos?
 
Via Benzinga
Analyst Scoreboard: 5 Ratings For Glaukos
 
Via Benzinga
How Is The Market Feeling About Glaukos?
 
Via Benzinga
Earnings Scheduled For February 20, 2025
 
Via Benzinga
This NetApp Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday
 
Via Benzinga
Peering Into Glaukos's Recent Short Interest
 
Via Benzinga
How Is The Market Feeling About Glaukos?
 
Via Benzinga
$1000 Invested In Glaukos 5 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Glaukos to Release Fourth Quarter and Full Year 2024 Financial Results after Market Close on February 20
From Glaukos Corporation
Via Business Wire
What 11 Analyst Ratings Have To Say About Glaukos
 
Via Benzinga
(GKOS) - Analyzing Glaukos's Short Interest
 
Via Benzinga
A Closer Look at 7 Analyst Recommendations For Glaukos
 
Via Benzinga
Navigating 11 Analyst Ratings For Glaukos
 
Via Benzinga
Glaukos Announces Participation in the J.P. Morgan Healthcare Conference
From Glaukos Corporation
Via Business Wire
Wall Street's Top 10 Stock Calls This Week - Saturday, Dec. 7
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Dec. 2-6, 2024. 
Via Talk Markets
Topics Stocks / Equities
This Constellation Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
 
Via Benzinga
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges. 
Via Benzinga
Glaukos Stock: A Deep Dive Into Analyst Perspectives (12 Ratings)
 
Via Benzinga
This Kohl's Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
 
Via Benzinga
Glaukos Announces Participation in Upcoming Investor Conferences
From Glaukos Corporation
Via Business Wire
Glaukos Reports 30% Boost In Glaucoma Sales, Improved Margins In Q3, Analyst Highlights Certain Headwinds
Glaukos Corporation's Q3 revenue grew 24% to $96.7 million, beating estimates, with an EPS loss of $(0.28). 2024 sales guidance raised despite anticipated headwinds. 
Via Benzinga
Glaukos Announces Third Quarter 2024 Financial Results
From Glaukos Corporation
Via Business Wire
Glaukos Announces Positive Topline Outcomes in Phase 3 Confirmatory Trial for Epioxa™, Achieving Primary Efficacy Endpoint and Demonstrating Favorable Tolerability and Safety
From Glaukos Corporation
Via Business Wire
Glaukos To Present Multiple Scientific Abstracts at the 2024 American Academy of Ophthalmology Annual Meeting
From Glaukos Corporation
Via Business Wire
Glaukos to Release Third Quarter 2024 Financial Results after Market Close on November 4
From Glaukos Corporation
Via Business Wire
Glaukos Announces Participation in Upcoming Investor Conferences
From Glaukos Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Starting at $3.75/week.

Subscribe Today